Techniques in Regional Anesthesia & Pain Management
Volume 10, Issue 1 , Pages 7-11, January 2006

Neuroaugmentation in the management of pelvic pain syndromes

  • Octavio Calvillo, MD, PhD

      Affiliations

    • Department of Anesthesiology, The Methodist Hospital Houston, Texas
    • Corresponding Author InformationAddress reprint requests and correspondence: Octavio Calvillo, MD, PhD, 6560 Fannin, Suite 1115, Houston, TX 77030.
  • ,
  • Uriah Guevara, MD

      Affiliations

    • Department of Anesthesiology and Center for Pain Instituto Nacional de la Nutricion, Mexico City, Mexico
  • ,
  • Hassan Chahadeh, MD

      Affiliations

    • Department of Anesthesiology, The Methodist Hospital Houston, Texas

The management of pelvic pain usually represents a challenge; neuroaugmentation of the sacral segmental nerves roots is probably one of the last options that pain physicians resort to. In properly selected patients, it can provide satisfactory results. In this article, we have reviewed some aspects relevant to pelvic pain and their treatment with this technique. Two techniques of neuroaugmentation are described: a transacral approach has been used extensively with good results for pelvic pain and urinary bladder dysfunction. A retrograde electrode placement technique from rostral lumbar segments has been published by some authors. It appears to be a reasonable and acceptable route to treat pelvic pain. The most common indications for sacral neuroaugmentation are: interstitial cystitis, vulvodynia, male chronic pain syndrome, and in some cases, sacroiliac joint pain. The mechanism of action of neuroaugmentation has not been defined; however, it seems that neuroaugmentation can induce release of inhibitory neurotransmitters in the spinal cord, in particular glycine and GABA; there is also evidence that substance P and other peptides may participate. It has also been proposed that neuroaugmentation may decrease the release of excitatory neurotransmitters like glutamate. The most unlikely mechanism to explain the analgesia of neuroaugmentation is endorphin release, since naloxone does not antagonize the effects of neuroaugmentation.

Keywords:  Pelvic pain , Spinal cord stimulation , Neuroaugmentation , Chronic pain , Perineal pain

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1084-208X(06)00005-X

doi:10.1053/j.trap.2006.02.004

Techniques in Regional Anesthesia & Pain Management
Volume 10, Issue 1 , Pages 7-11, January 2006